ACS.F ATH. MEDIC.CENTER
- Market cap
- EUR 107M
- P/E
- -
- P/B
- 1.02x
- ROE
- -4.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is ACS.F undervalued?
Graham numberThe Graham number of ATH. MEDIC.CENTER cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ATH. MEDIC.CENTER fundamental analysis
No fundamental analysis for ATH. MEDIC.CENTER yet.
ATH. MEDIC.CENTER stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ATH. MEDIC.CENTER
Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for breast, gastrointestinal, hematologic malignancies, lover and pancreatic, lung, prostate, and other common cancers; heart and vascular, robotic surgery, including general, gynecologic, and urology services; and neuro- and spine surgery services. It also provides medical services for range of orthopedics, such as foot …
Full company profileATH. MEDIC.CENTER financial statements
ATH. MEDIC.CENTER annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 226M | 233M | 258M | 270M | 276M |
| Gross Profit | 57.8M | 56.8M | 66.6M | 60.8M | 56.1M |
| Operating Income | 20.6M | 16.7M | 20.8M | 12.0M | 3.89M |
| EBITDA | - | 32.1M | 38.0M | 32.0M | 27.8M |
| Net Income | 15.1M | 6.85M | 8.08M | 1.78M | -4.67M |
| EPS | 0.17 | 0.08 | 0.09 | 0.02 | -0.05 |
| Balance Sheet | |||||
| Total Assets | 416M | 418M | 477M | 496M | 533M |
| Total Liabilities | 314M | 315M | 369M | 387M | 429M |
| Shareholders' Equity | 102M | 103M | 109M | 109M | 104M |
| Cash & Short-term Investments | 52.0M | 16.7M | 22.0M | 17.5M | 31.3M |
| Cash Flow | |||||
| Operating Cash Flow | 15.7M | 124K | 26.1M | 46.4M | 5.09M |
| Capital Expenditure | 11.3M | 15.9M | 22.4M | 26.6M | 16.9M |
| Free Cash Flow | 4.47M | -15.8M | 3.78M | 19.8M | -11.8M |
| Ratios | |||||
| ROE | 14.7% | 6.6% | 7.4% | 1.6% | -4.5% |
| ROA | 3.6% | 1.6% | 1.7% | 0.4% | -0.9% |
| Net Profit Margin | 6.7% | 2.9% | 3.1% | 0.7% | -1.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
ATH. MEDIC.CENTER dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jul 22, 2024
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | EUR 1.73M | 0.02 | 97.1% |
| 2023 | EUR 61.0K | 0.00 | 0.8% |
| 2022 | - | - | - |
| 2021 | EUR 81.0K | 0.00 | 0.5% |
| 2009 | - | - | - |
| 2008 | - | - | - |
| 2007 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns ATH. MEDIC.CENTER
- Insiders 80.82%
- Institutions 0.03%
- Public & others 19.16%
- Shares outstanding 86.7M
ATH. MEDIC.CENTER company profile
- Company name
- ATH. MEDIC.CENTER
- Ticker
- ACS.F
- ISIN
- GRS147233001
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 3,505
- Fiscal year end
- December
- Address
- 5-7 Distomou Street, Athens, Greece, 15125
- Phone
- 30 210 61 98 100
- Website
- iatriko.gr
About ATH. MEDIC.CENTER
Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for breast, gastrointestinal, hematologic malignancies, lover and pancreatic, lung, prostate, and other common cancers; heart and vascular, robotic surgery, including general, gynecologic, and urology services; and neuro- and spine surgery services. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoulder, and spine; sports injuries; plastic Surgeries for face, body, breast, obesity, reconstructive plastic surgery, scar correction, and sex reassignment; bariatric surgery for gastric banding, sleeve gastrectomy, and biliopancreatic diversion with duodenal switch; and chronic diseases, including diabetes, endocrinology, heart failure, high blood pressure, pain management, respiratory system, stroke, and thyroid conditions. In addition, the company operates wellness and prevention centers; and offers medical education, training, and practice services. The company was founded in 1983 and is based in Athens, Greece.
ATH. MEDIC.CENTER management
10- Dr. Georgios V. ApostolopoulosPresident of the Board · born 1941
- Dr. Vasilios G. ApostolopoulosCEO & Executive Director
- Mr. Christos G. ApostolopoulosFirst Executive Vice President of the Board
- Mr. Petros D. AdamopoulosChief Financial Officer
- Mr. Panagiotis Ch. KatsichtisChief Accountant
- Mr. Fanis NezeritisHead of Technical Department
- Theodora AnagnostopoulouDepartment Head of Investor Relations
- Mr. Thodoris PapafotopoulosHuman Resource Manager · born 1961
- Mr. Georgios ZerdilasExecutive Director
- Mr. Georgios BoutsioukosExecutive Director